Home Biosimilar Antibodies Immunology & Inflammation IL Receptor antibody Nemolizumab (Anti-IL-31Ra) For research use only.
Not for use in humans.

Nemolizumab (Anti-IL-31Ra)

Synonyms: CIM331

Nemolizumab (Anti-IL-31Ra) is a humanized monoclonal antibody, targeting IL-31Ra. It inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD). MW:145.5 KD.

Nemolizumab (Anti-IL-31Ra)

Purity & Quality Control

≥99

Choose Selective IL Receptor Inhibitors

Biological Activity

Description Nemolizumab (Anti-IL-31Ra) is a humanized monoclonal antibody, targeting IL-31Ra. It inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD). MW:145.5 KD.

Product Details

CAS No. 1476039-58-3
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nemolizumab (Anti-IL-31Ra) | Nemolizumab (Anti-IL-31Ra) supplier | purchase Nemolizumab (Anti-IL-31Ra) | Nemolizumab (Anti-IL-31Ra) cost | Nemolizumab (Anti-IL-31Ra) manufacturer | order Nemolizumab (Anti-IL-31Ra) | Nemolizumab (Anti-IL-31Ra) distributor